gadolinium has been researched along with procarbazine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Bruin, HG; de Wit, MC; Eijkenboom, W; Sillevis Smitt, PA; van den Bent, MJ | 1 |
Kim, YZ; Lee, EH; Sung, KH | 1 |
1 review(s) available for gadolinium and procarbazine
Article | Year |
---|---|
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artifacts; Astrocytoma; Brain Edema; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cohort Studies; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Gadolinium; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Patient Selection; Procarbazine; Temozolomide; Vincristine | 2004 |
1 trial(s) available for gadolinium and procarbazine
Article | Year |
---|---|
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artifacts; Astrocytoma; Brain Edema; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cohort Studies; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Gadolinium; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Patient Selection; Procarbazine; Temozolomide; Vincristine | 2004 |
1 other study(ies) available for gadolinium and procarbazine
Article | Year |
---|---|
Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Contrast Media; Disease-Free Survival; DNA-Binding Proteins; Drug Administration Schedule; Female; Follow-Up Studies; Gadolinium; Humans; Interferon Regulatory Factors; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Odds Ratio; Procarbazine; Prospective Studies; Recurrence; Regulatory Factor X Transcription Factors; Severity of Illness Index; Transcription Factors; Tumor Suppressor Protein p53; Vincristine; X-Box Binding Protein 1 | 2011 |